"Conditions affecting women’s pelvic organs and pelvic floor—the muscles and connective tissues that support the pelvic organs—are common. Fortunately, so is relief from those conditions. In nearly all cases, symptoms improve with treatment. At Boston Urogynecology Associates, an affiliate of Mount Auburn Hospital, you’ll find comprehensive care from leading female pelvic medicine and reconstructive surgery (FPMRS) specialists. Count on our urogynecologists to accurately diagnose your condition and create a personalized treatment plan to improve your symptoms and your quality of life."

During the past decade, Boston Urogynecology Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston Urogynecology Associates" #1 collaborator was "Allergan" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Boston Urogynecology Associates" are "Stress Urinary Incontinence" (4 trials), "Overactive Bladder" (2 trials), "Pelvic Organ Prolapse" (2 trials), "Urge Incontinence" (2 trials) and "Myofascial Pelvic Pain" (1 trials). Many other conditions were trialed in "Boston Urogynecology Associates" in a lesser frequency.

Most popular intervention types in "Boston Urogynecology Associates" are "Device" (4 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Altis Sling" (1 trials), "Axis" (1 trials), "BTL EMSELLA Active treatment" (1 trials), "BTL EMSELLA Sham Treatment" (1 trials) and "Bicarbonate protocol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Boston Urogynecology Associates" are 8 trials for "Female" genders.

Currently, there are NaN active trials in "Boston Urogynecology Associates". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Boston Urogynecology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Boston Urogynecology Associates, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".